Toggle navigation
Home
Search
Services
Blog
Contact
About
Task A10: Efficacy Testing of Therapeutics for Hepatitis C
Kmt Hepatech, Inc., Edmonton, AB, Canada
Search grants from Kmt Hepatech, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Interactive Omics: Black raspberry metabolites and the oral microbiome in smokers
Interdisciplinary Training in Cancer, Aging and End-of-Life Care
Opposing Modulation of K+ Channels by a Redox Sensor
Molecular Basis for Rapid Hepatitis a Virus Replication
Utilization of Epidermal Cell Model From Human Skin
Recently added grants:
The formation of Heterochromatin on evolving Y chromosomes
The mechanistic role of METTL14 in UVB-induced skin tumorigenesis
Lipocalin 2 as a regulator of phospholipid metabolism in adipose mitochondrial bioenergetics
Epithelial Responses to Bacterial Invasion
Role of Base Excision Repair in Limiting Hepatocellular Carcinomas
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research and Development Contracts (N01)
Project #
272201000016I-0-27200001-1
Application #
8539576
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2012
Total Cost
$1,292,503
Indirect Cost
Institution
Name
Kmt Hepatech, Inc.
Department
Type
DUNS #
202499542
City
Edmonton
State
AB
Country
Canada
Zip Code
76 2-E1
Related projects
NIH 2012
N01 AI
Task A10: Efficacy Testing of Therapeutics for Hepatitis C
/ Kmt Hepatech, Inc.
$1,292,503
NIH 2011
N01 AI
Task A10: Efficacy Testing of Therapeutics for Hepatitis C
Kneteman, Norman / Kmt Hepatech, Inc.
$1,260,145
NIH 2010
N01 AI
Animal Models of Infectious Diseases
/
$50,000
Comments
Be the first to comment on this grant